Effect of diadenosine phosphates on human umbilical vessels: novel platelet‐derived vasoconstrictors.

27Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The responses of human isolated umbilical artery to the novel platelet‐ derived mediators, diadenosine phosphates, P1,P5‐di(adenosine‐ 5′)pentaphosphate (AP5A) and P1,P6‐di(adenosine‐5′)hexaphosphate (AP6A) were studied in vitro. AP5A (1 nM‐300 microM; n = 7) and AP6A (1 nM‐30 microM; n = 5) produced transient concentration‐dependent contractions. Responses to AP5A were unaffected by co‐incubation with indomethacin (10 microM; n = 4), NGmonomethyl‐L‐arginine (L‐NMMA; 300 microM; n = 4) and theophylline (1 microM; n = 5). These results demonstrate that diadenosine phosphates have constrictor effects on human blood vessels in vitro and are consistent with a role for these platelet‐derived mediators in the regulation of blood vessel tone. Copyright © 1995, Wiley Blackwell. All rights reserved

Cite

CITATION STYLE

APA

Davies, G., MacAllister, R., Bogle, R., & Vallance, P. (1995). Effect of diadenosine phosphates on human umbilical vessels: novel platelet‐derived vasoconstrictors. British Journal of Clinical Pharmacology, 40(2), 170–172. https://doi.org/10.1111/j.1365-2125.1995.tb05773.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free